DevicePMAs@therightstef:P160043_S012 JSON TXT

Approval for the Resolute Onyx Zotarolimus-Eluting Coronary Stent System. The device is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions of length <= 35 mm in native coronary arteries with reference vessel diameters of 2.0 mm to 5.0 mm. In addition, the Resolute Onyx Zotarolimus-Eluting Coronary Stent System is indicated for treating de novo chronic total occlusions.

projects that include this document

Unselected / annnotation		Selected / annnotation
blah6_medical_device 0 (0) PMA_Manual 0 (0) PMA_MER 23 (23) test-2 0 (0) blah6 0 (0) med-device 0 (0) consensus_PMA_Age_Indications 0 (0) age_PMA_annotations 0 (0) Age_blah 0 (0) PMA_age_indications 0 (0) updated_tagging_age_PMA_annotations 0 (0)

TAB JSON ListView MergeView

DevicePMAs@therightstef:P160043_S012 JSONTXT

projects that include this document

DevicePMAs@therightstef:P160043_S012 JSON TXT